Chronic Low Grade Inflammation in Pathogenesis of PCOS
Open accessThe DOI matches its Crossref record; 97 of the 99 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) is a one of the most common endocrine disorders, with a prevalence rate of 5–10% in reproductive aged women. It’s characterized by (1) chronic anovulation, (2) biochemical and/or clinical hyperandrogenism, and (3) polycystic ovarian morphology. PCOS has significant clinical implications and can lead to health problems related to the accumulation of adipose tissue, such as obesity, insulin resistance, metabolic syndrome, and type 2 diabetes. There is also evidence that PCOS patients are at higher risk of cardiovascular diseases, atherosclerosis, and high blood pressure. Several studies have reported the association between polycystic ovary syndrome (PCOS) and low-grade chronic inflammation. According to known data, inflammatory markers or their gene markers are higher in PCOS patients. Correlations have been found between increased levels of C-reactive protein (CRP), interleukin 18 (IL-18), tumor necrosis factor (TNF-α), interleukin 6 (IL-6), white blood cell count (WBC), monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1α (MIP-1α) in the PCOS women compared with age- and BMI-matched controls. Women with PCOS present also elevated levels of AGEs and increased RAGE (receptor for advanced glycation end products) expression. This chronic inflammatory state is aggravating by obesity and hyperinsulinemia. There are studies describing mutual impact of hyperinsulinemia and obesity, hyperandrogenism, and inflammatory state. Endothelial cell dysfunction may be also triggered by inflammatory cytokines. Many factors involved in oxidative stress, inflammation, and thrombosis were proposed as cardiovascular risk markers showing the endothelial cell damage in PCOS. Those markers include asymmetric dimethylarginine (ADMA), C-reactive protein (CRP), homocysteine, plasminogen activator inhibitor-I (PAI-I), PAI-I activity, vascular endothelial growth factor (VEGF) etc. It was also proposed that the uterine hyperinflammatory state in polycystic ovary syndrome may be responsible for significant pregnancy complications ranging from miscarriage to placental insufficiency. In this review, we discuss the most importance evidence concerning the role of the process of chronic inflammation in pathogenesis of PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“COCs also exacerbate the inflammatory state present in these patients, which is likely related to increased aldosterone–renin ratio and CRP [12,14].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [12]
Experimental — accuracy not yet measuredIn the citing paper
“The release of inflammatory markers is associated with long-term metabolic complications and high cardiovascular risk [12].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947 · cited 1×
“Compared with control women, patients with PCOS presented higher circulating concentrations of markers such as homocysteine, asymmetric dimethylarginine, and increased superoxide dismutase activity and decreased glutathione levels and paraoxonase-1 activity [2].”
BackgroundMacrophage-mediated inflammation in metabolic disease
Chawla, A., Nguyen, K. D., & Goh, Y. P. S. (2011) · Nature reviews. Immunology · doi:10.1038/nri3071 · Cited by 1,314
Adapting to obesity with adipose tissue inflammation
Reilly, S. M., & Saltiel, A. R. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.90 · Cited by 1,204
Chronic Inflammation in Obesity and the Metabolic Syndrome
Monteiro, R., & Azevedo, I. (2010) · Mediators of Inflammation · doi:10.1155/2010/289645 · Cited by 1,186 · cited 1×
“Obesity is a metabolic condition characterized by chronic inflammation state with higher pro-inflammatory cytokines, chemokines, and oxidative stress (OS) markers levels [5,6].”
BackgroundChronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
Zatterale, F., Longo, M., Naderi, J., Raciti, G. A., Desiderio, A., Miele, C., & Beguinot, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01607 · Cited by 1,180
Inflammation and insulin resistance
de Luca, C., & Olefsky, J. M. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.057 · Cited by 1,161
Metabolic Inflammation and Insulin Resistance in Obesity
Wu, H., & Ballantyne, C. M. (2020) · Circulation Research · doi:10.1161/circresaha.119.315896 · Cited by 1,059
Cited by
Items 301–400 of 731
Huang, X. Y., Yin, Z., Xu, J., Wu, H., & Wang, Y. (2024) · Reproductive Sciences · doi:10.1007/s43032-024-01538-3 · Cited by 7
Niu, Y., Wang, N., & Xu, Q. (2024) · Reproductive Sciences · doi:10.1007/s43032-024-01619-3 · Cited by 6
Bai, Y., Liu, Y., Wang, Y., Liu, X., Wang, Y., Liu, H., Yi, H., Xu, C., & Zhang, F. (2024) · Reproductive Sciences · doi:10.1007/s43032-024-01631-7 · Cited by 6
Lower Serum ATG7 Levels Linked to Insulin Resistance in Women with Polycystic Ovary Syndrome
Lu, L., Wu, B., Peng, C., Zhang, W., Zhao, Y., Huang, C., & Long, Y. (2024) · Medical Science Monitor · doi:10.12659/msm.944556 · Cited by 6
Relation of the intense physical exercise and asprosin concentrations in type 2 diabetic rats
Katar, M., & Gevrek, F. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102501 · Cited by 6
Zhu, Q., Wang, Y., Xu, L., Shi, M., Meng, Y., Shao, C., Lu, Y., He, Y., Huang, J., Li, X., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae596 · Cited by 5
Zhao, X., Wang, J., Sun, D., Xu, D., & Lu, Y. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae375 · Cited by 16
Jian, X., Shi, C., Xu, T., Liu, B., Zhou, L., Jiang, L., & Liu, K. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2440063 · Cited by 6
Immunological status in patients with amenorrhea (literature review)
Absatarova, Y. S., Evseeva, Y. S., Andreeva, E. N., Zuraeva, Z. T., Sheremetyeva, E. V., Grigoryan, O. R., & Михеев, Р. К. (2024) · Problems of Endocrinology · doi:10.14341/probl13456 · Cited by 5
From root to Recovery: The role of herbs in polycystic ovary syndrome management
Zafar, N.-U.-A., Qureshi, R., Siddiqa, A., Naqvi, S. A. M., Waheed, F., Mashwani, Z., Ali, A., Ramírez, K. A. H., Medina‐Pérez, G., Peláez-Acero, A., et al. (2025) · Steroids · doi:10.1016/j.steroids.2025.109606 · Cited by 6
Comprehensive Overview of PCOS: Exploring Etiology, Diagnosis, and Treatment Approaches
Singh, S. K., Gori, P., Patel, P., & Paul, A. (2025) · Current Pharmacology Reports · doi:10.1007/s40495-025-00419-w · Cited by 5
[Proinflammatory cytokines in polycystic ovarian syndrome].
García-Sáenz, M. R., Ferreira‐Hermosillo, A., & Lobaton-Ginsberg, M. (2022) · PubMed Central · Cited by 18
Lin, H., Tseng, Y., Cheng, P., Hao, C., Tu, Y.-C., Yeh, B.-C., & Shen, K. (2023) · Natural Product Communications · doi:10.1177/1934578x231179416 · Cited by 5
The PCOS puzzle: putting the pieces together for optimal care
Dar, M. A., Maqbool, M., & Ara, I. (2023) · International Journal of Adolescent Medicine and Health · doi:10.1515/ijamh-2023-0102 · Cited by 7
ApoC3 is expressed in oocytes and increased expression is associated with PCOS progression
Zhou, J., Mo, H., Feng, Q., Li, L., & La, J. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01263-6 · Cited by 5
Screening and verification of genes related to polycystic ovary syndrome
Li, X., Wang, C., Yang, H., Pei, D., Liu, Y., Yan, S., & Li, Y. (2023) · Journal of International Medical Research · doi:10.1177/03000605221147444 · Cited by 5
Asemi, R., Asouri, S. A., Aghadavod, E., & Jamilian, M. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002349 · Cited by 4
Keyif, B., Yurtçu, E., Başbuğ, A., Yavuzcan, A., & Göynümer, G. (2025) · Metabolites · doi:10.3390/metabo15030182 · Cited by 5
Opydo-Szymaczek, J., Wendland, N., Formanowicz, D., Blacha, A., Jarząbek‐Bielecka, G., Radomyska, P., Kruszyńska, D., & Mizgier, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14176159 · Cited by 4
Vitamin D Deficiency and VDR Gene Variants in Polycystic Ovary Syndrome: A Case–Control Study
Chakraborty, S., Pal, R., Begum, F., Naskar, T. K., Das, N., & Basu, B. R. (2025) · Reproductive Sciences · doi:10.1007/s43032-025-01991-8 · Cited by 6
Mohanty, A., Bashir, B., Kolekar, K. A., Acharya, A., Gulati, M., Chaitanya, M., Gupta, M., Patle, D., Gupta, G., & Singh, S. K. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-02015-2 · Cited by 4
Dutta, S., Sengupta, P., Chhikara, B. S., Formicki, G., Rosas, I. M., & Roychoudhury, S. (2025) · Toxics · doi:10.3390/toxics13110927 · Cited by 5
Su, J., Zhang, Y., & Jiang, X. (2025) · BMC Women s Health · doi:10.1186/s12905-025-04134-y · Cited by 4
Lu, F., Yu, H., Shi, B., Feng, J., Liu, Y., Guan, M., Yu, J., Gao, Z., Gao, J., Ma, H., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1716287 · Cited by 4
Exosomes for Polycystic Ovary Syndrome Treatment: Mechanisms and Therapeutic Potential
Liu, P., Sha, Y., Yang, H., & Liu, T. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s574044 · Cited by 5
Interconnection between polycystic ovary syndrome, immune disorders, and reproductive outcomes
Romero, T. B., Sobral, D. D. S., Aguiar, L. A. A., PONTE, H. A.-A., FILHO, R. E. R., MONTENEGRO, A. L. R., Maia, M. G. R., Marques, T. G., Martins, L. D. O., & Cavalcante, M. B. (2026) · Reproduction and Fertility · doi:10.1530/raf-25-0186 · Cited by 5
Yang, H., Zhao, S., Yang, L., Quan, X., Xue, X., Liu, Y., Yao, K., Wang, R., Liu, Q., Zou, K., et al. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124392 · Cited by 4
Subakathulla, S., Manoj, N., Patanwala, A. M., Premvignesh, P. A., Alobaid, Y. M., Majie, A., Gorain, B., Dutta, S., Sengupta, P., Rosas, I. M., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1825853 · Cited by 5
Li, Z., Liu, Y., Liu, H., Wu, Z., Xu, C., & Zhang, F. (2022) · Reproductive and Developmental Medicine · doi:10.1097/rd9.0000000000000025 · Cited by 4
Bai, L., Gao, X., Guo, Y., Gong, J., Li, Y., Huang, H., & Liu, X. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.15253 · Cited by 4
Liao, C.-C., Chien, C., Yu, T., & Li, J. (2023) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s442816 · Cited by 4
Wal, A., Dash, B., Jaiswal, V., Gupta, D., & Mishra, A. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13587-3.00018-7 · Cited by 7
The adipokines progranulin and omentin can directly regulate feline ovarian granulosa cell functions
Sirotkin, A. V., Fabová, Z., Loncová, B., Bauerová, M., & Harrath, A. H. (2024) · Research in Veterinary Science · doi:10.1016/j.rvsc.2024.105321 · Cited by 4
Planey, T., & Grosel, J. M. (2024) · JAAPA · doi:10.1097/01.jaa.0000000000000141 · Cited by 4
Biomechanical changes in females with poly cystic ovarian syndrome: a case–control study
Kamal, E., Hamada, H. A., Ashour, R. S., Yousef, A. M., & Elbesh, R. M. (2025) · Scientific Reports · doi:10.1038/s41598-025-93481-9 · Cited by 4
Zhang, H., Yang, H., Wu, Y., Shi, Y., Xu, M., Zhang, Y., Chen, H., & Sun, L. (2025) · Lupus Science & Medicine · doi:10.1136/lupus-2024-001468 · Cited by 6
PLK2 as a key regulator of glycolysis and immune dysregulation in polycystic ovary syndrome
Ma, H., Qi, D., Xu, Y., Shang, T., Si, Y., Chen, W., Zhao, H., & Ren, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1610713 · Cited by 5
Acetylation reader BRD4-driven TXNIP transcription enhances NLRP3 inflammasome activation in PCOS
Weng, Y., Zhang, Y., Dong, W., Zhu, Z., Xiang, Z., Yan, G., Wang, H., Wen, Y., Liu, M., Wang, D., et al. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05925-0 · Cited by 4
Time Perspective as a Mediator of Depressive Symptoms in Patients with Polycystic Ovary Syndrome
Adamczak, A., Płotek, W., Głowińska, A., Sobol, M., Wysocka, E., Polak, G., Dymanowska-Dyjak, I., Spaczyńska, J., Adamczak, Ł., & Banaszewska, B. (2023) · Healthcare · doi:10.3390/healthcare11070993 · Cited by 5
Ma, Q., Yang, Y., Chen, S., Cheng, H., Gong, P., & Hao, J. (2024) · Molecular Biology Reports · doi:10.1007/s11033-023-09134-5 · Cited by 4
Zhang, J., Li, Y., Gong, A., & Wang, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1442483 · Cited by 4
Hu, Y., Chen, B., Pan, Y., Xing, K., Xiao, Z., Sheng, B., Li, J., Dong, H., & Lv, F. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1374718 · Cited by 5
The emerging roles of N6-methyladenosine (m6A) deregulation in polycystic ovary syndrome
Jiang, L., Xiao, J., Xie, L., Zheng, F., Ge, F., Zhao, X. Y., Qiang, R., Fang, J., Liu, Z., Xu, Z., et al. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01690-7 · Cited by 5
a1-antitrypsin, a new biomarker of polycystic ovary syndrome by changing its expression and rhythm
Li, N., Shen, B., Cao, W., Chen, R., He, R., Li, Q., Xu, L., & Liu, Y. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01698-z · Cited by 4
Uhunmwangho, E. G., Oniyide, A. A., Areloegbe, S. E. J., Soetan, O. A., Akintayo, C. O., Aturamu, A., & Olaniyi, K. S. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-022-01097-x · Cited by 7
Hançerlioğulları, N., Tokmak, A., Güney, G., Pekcan, M. K., Koc, E. M., Çandar, T., & Üstün, Y. E. (2022) · Medicine · doi:10.1097/md.0000000000032326 · Cited by 7
Morshedzadeh, N., Behrouz, V., & Ahmadi, A. R. (2025) · Scientific Reports · doi:10.1038/s41598-025-24046-z · Cited by 3
Multiomics in polycystic ovarian syndrome
Jabeen, F., Ahmad, R., Rasool, S., Ali, A., & Ganie, S. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23971-7.00010-9 · Cited by 4
Rastegari, H., Kazemnejad, S., Roodbari, N. H., & Ansaripour, S. (2024) · Current Stem Cell Research & Therapy · doi:10.2174/011574888x298902240523103352 · Cited by 4
Influence of Suppressor of Cytokine Signaling 1 (SOCS1) Gene Variations on Polycystic Ovary Syndrome
Rakhshanizade, N., Sargazi, S., Karajibani, M., Majidpour, M., Karajibani, A., Montazerifar, F., & Ghasemi, M. (2024) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-024-01248-2 · Cited by 3
miRNAs in ovarian disorders: Small but strong cast
Tafazoli, P., Rad, H. M., Mashayekhi, M., Siadat, S. F., & Fathi, R. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155709 · Cited by 4
Liu, Y., Gengxiao, Y., Wu, Y., Li, Y., Hu, X., & Bie, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-03396-8 · Cited by 4
Chen, L., Fang, C.-P., Chen, Y., Gu, W.-H., Wang, S.-L., Niu, N., & Zhang, Q. (2025) · International Journal of Women s Health · doi:10.2147/ijwh.s526092 · Cited by 3
Vavrusakova, B., Bartošová, R., Svoboda, M., & Moráň, L. (2025) · Klinicka onkologie · doi:10.48095/ccko2025270 · Cited by 3
Lu, R., Gao, Y., Sun, C., Wang, M., Huang, T., Yang, G., & Chen, Y. (2025) · International Journal of Emergency Medicine · doi:10.1186/s12245-025-00981-6 · Cited by 3
Xu, Y., Ning, L., Wang, R., Ma, H., Zhao, H., Si, Y., Xiu, L., & Ren, Q. (2026) · Reproductive Toxicology · doi:10.1016/j.reprotox.2026.109200 · Cited by 3
Liu, X., & Sun, T. (2026) · Reproduction · doi:10.1093/reprod/xaag026 · Cited by 3
Hong, L., Huang, C., Mo, M., Wang, X., Sun, Q., Zhang, R., & Liu, S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1784682 · Cited by 3
Adiponectin and Polycystic Ovary Syndrome in Adolescent Girls: A Systematic Review and Meta-Analysis
Fernando, S., & Ramdass, P. V. A. K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27093950 · Cited by 3
Sharata, E. E., Abdel-Samea, A. S., Ibrahim, L. Y., Mamdouh, M., Khalid, N., Rabea, M., Mohamed, G. H., Abdelnaser, M., & Mohyeldin, R. H. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05559-4 · Cited by 3
Yuan, D., Hao, X., Luo, J., Liu, Y., Du, P., & Yang, Z. (2026) · Cell Biochemistry and Function · doi:10.1002/cbf.70248 · Cited by 3
Popa, E., Chiş-Şerban, A.-A., & Coman, A. E. (2023) · Medic ro · doi:10.26416/med.151.1.2023.7837 · Cited by 3
Marlina, U., Maulitanti, S. D., Annisa, Y., & Masitha, D. (2023) · Jurnal Pendidikan Indonesia · doi:10.59141/japendi.v4i05.1821 · Cited by 3
Relationships between nonalcoholic fatty liver disease and polycystic ovary syndrome
Манжалій, Е., Татарчук, Т. Ф., Tutchenko, T. М., Косей, Н. В., & Mnevets, R. O. (2023) · Reproductive Endocrinology · doi:10.18370/2309-4117.2023.70.40-45 · Cited by 3
Bai, H., Zhang, S., Huang, J., Diao, K., Li, C., & Wang, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-74347-y · Cited by 3
Lan, Y., Jin, B., Fan, Y., Huang, Y., & Zhou, J. (2025) · Biochemical Genetics · doi:10.1007/s10528-024-11010-1 · Cited by 4
Mladenov, V., Radanova, M. A., Galcheva, S., & Iotova, V. (2025) · Applied Sciences · doi:10.3390/app15052772 · Cited by 3
Recent trends in polycystic ovary syndrome treatment based on adult stem cell therapies
Park, H., Han, J. W., & Kim, G. J. (2025) · Daehan saengsik uihak hoeji/Clinical and experimental reproductive medicine · doi:10.5653/cerm.2024.07248 · Cited by 3
Femi-Olabisi, F. J., Oyerinde, O. R., Faokunla, O. O., Omar, S. A., Igene, P. E., Asaluwala, O. E., Adeoye, B. O., & Oladoye, O. O. (2025) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2025.100245 · Cited by 3
Beneficial Effects of Alchemilla vulgaris in DHEA-Induced Rat Model of Polycystic Ovary Syndrome
Korun, Z. E. U., Göçmez, S. S., Rençber, S. F., Sarıhan, K. K., Eraldemir, F. C., AKPULAT, H. A., Şahin, D., & Yıldız, Ş. (2025) · Reproductive Sciences · doi:10.1007/s43032-025-01885-9 · Cited by 3
Therapeutic Potential of GeGen Decoction for the Treatment of Polycystic Ovary Syndrome
Qian, Y., Bayoude, A., Zhou, H., Shen, Y., & Chai, C. (2025) · The FASEB Journal · doi:10.1096/fj.202500192rr · Cited by 3
Knowledge graph and bibliometric analysis of inflammatory indicators in ovarian cancer
Zhang, L., Guo, L., Wang, H., Yang, H., & Dong, J. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1533537 · Cited by 3
Yousuf, S. D., Ganie, M. A., Mudassar, S., Shafi, H., Ibrahim, S., Jeelani, H., Rashid, G., Zargar, M. A., & Rashid, F. (2022) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1916_21 · Cited by 3
Structural and functional changes in rat uterus induced by neonatal androgenization
Chávez‐Genaro, R., Toledo, A., Hernández, K., & Anesetti, G. (2022) · Journal of Molecular Histology · doi:10.1007/s10735-022-10106-5 · Cited by 5
Zohrabi, T., Sheikhha, M. H., Jambarsang, S., Nadjarzadeh, A., D, A. A. M., & Mozaffari–Khosravi, H. (2023) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.18502/ijrm.v21i5.13496 · Cited by 4
Women’s reproductive risk and genetic predisposition in type 2 diabetes: A prospective cohort study
Liu, X., Liu, X., Huang, N., Yang, Z., Zhang, Z., Zhuang, Z., Jin, M. S., Li, N., & Huang, T. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111121 · Cited by 3
Yan, Y., Di, F., Zhang, R., Song, L., Zhang, R., & Qiu, J. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-024-01374-8 · Cited by 5
Seed cycling: Approach for polycystic ovarian syndrome
Zafar, M., Rabail, R., Bibi, S., Jebreen, A. M. Y., Khan, M. A., & Aadil, R. M. (2024) · Food and Humanity · doi:10.1016/j.foohum.2024.100274 · Cited by 4
Proinflammatory Cytokines in Women with PCOS in Atypical Pathogen Infections
Chudzicka-Strugała, I., Gołębiewska, I., Brudecki, G. P., Elamin, W. F., Banaszewska, B., Chudzicka-Adamczak, M., Strugała, D., & Zwoździak, B. (2025) · Diagnostics · doi:10.3390/diagnostics15131669 · Cited by 4
Zhao, X., Zhang, Y., Fan, Q., He, Y., Ma, Y., Sun, M., Zhao, Y., Jiang, Y., & Jia, D. (2025) · Functional & Integrative Genomics · doi:10.1007/s10142-025-01686-y · Cited by 3
Dai, Z., Chen, Y., & Liu, C. (2024) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.16088 · Cited by 2
Hao, Y., Yin, Q., Hu, F. C., Liu, X., Yang, Y., Sun, F., & Yan, X. (2024) · International Journal of Endocrinology · doi:10.1155/2024/2449037 · Cited by 2
Çağlar, Y. A., & Taşkın, M. İ. (2024) · Medicina · doi:10.3390/medicina60122102 · Cited by 2
Review on: Women with Polycystic Ovary Syndrome
Gusain, N., Anjankar, A. P., Ambad, R. S., Jha, R. K., & Jha, R. K. (2025) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_1995_24 · Cited by 4
Wang, Y., Ding, J., Min, Y., Zhang, Y., Ming, J., & Yin, T. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70108 · Cited by 2
Luo, M., Tian, X., Li, L., Zhang, G., Liu, W., Mei, L., Li, H., You, X., Zhang, D., Zhou, M., et al. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1633254 · Cited by 2
Zahedi, Y., Bonyanpour, S., Alizadeh, S. D., Ravankhah, S., Zare, A., Izadi, B., Apelian, S., Sekhavati, E., & Tabrizi, R. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1599782 · Cited by 3
Follicular ovarian cysts, lactose persistence and microbiome: is there a connection?
Мохній, В. В., Makarchuk, O. M., Pavlushynskyi, Y., Rymarchuk, M., Kyshakevych, I. T., & Perkhulyn, O. M. (2025) · Reproductive health of woman · doi:10.30841/2708-8731.5.2025.337949 · Cited by 2
To explore the relationship between endometrial hyperemia and polycystic ovary syndrome
Wang, S., Li, F., Zhang, W., Bao, H., & Hao, C. (2025) · Open Life Sciences · doi:10.1515/biol-2025-1154 · Cited by 2
Ahmad, R., Frishman, W. H., & Aronow, W. S. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000001054 · Cited by 4
Gheymoumi, H., Shayesteh, S., Amiri-Andebili, M., Gheymoumi, N., Sharifi, F., & Dehpour, A. R. (2025) · Iranian journal of pharmaceutical research · doi:10.5812/ijpr-164861 · Cited by 2
Approaches to Infertility Management in Overweight Patients with Polycystic Ovary Syndrome
Alnaeli, L. R., Godid, F. A. S., & Salama, J. A. S. (2025) · Journal of Obstetrics Gynecology and Cancer Research · doi:10.24200/jogcr.10.11.835 · Cited by 2
Eriksson, M. B., Hultström, M., Åberg, M., Lipcsey, M., Frithiof, R., & Larsson, A. O. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311419 · Cited by 2
Zhang, Y., Ma, H.-G., Sun, P., Liu, K., Wang, J., & Zhao, W. (2025) · Medicine · doi:10.1097/md.0000000000046532 · Cited by 2
Tang, L., Liu, H., Pang, Y., Wang, G., Wang, Z., & Lv, T. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1738172 · Cited by 2
Liu, J., Yang, H., Xiao, Z.-Y., Xie, J.-H., Su, L., Yi-ting, L., Zheng, X., Hu, W.-H., Fu, S.-J., Li, C.-L., et al. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1730714 · Cited by 3
Akbaş, B., Dinç, G., Akbaş, A., Ercan, G., Aygün, H., & Erbaş, O. (2026) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/s44411-026-00514-4 · Cited by 2
Weidner, A. E., Vann, K., Hodowanec, A. I., Ivey, D., Roy, A., Sechrist, Z. R., Cole, C. L., & Astapova, O. (2026) · Endocrinology · doi:10.1210/endocr/bqag025 · Cited by 3
Li, Q., Wu, Y., Chen, L., & Wang, R. (2026) · Current Obesity Reports · doi:10.1007/s13679-026-00703-w · Cited by 2
Zhang, X., Lin, L., & Ge, H. (2026) · Medicine · doi:10.1097/md.0000000000048005 · Cited by 4
Metadata
- Authors
- Rudnicka, E., Suchta, K., Grymowicz, M., Calik-Ksepka, A., Smolarczyk, K., Duszewska, A. M., Smolarczyk, R., & Meczekalski, B.
- Affiliations
- Medical University of Warsaw (PL)
- Warsaw University of Life Sciences (PL)
- Department of Gynaecological Endocrinology, Poznan University of Medical Sciences, 60-535 Poznan, Poland
- Corresponding author
- Rudnicka, Ewa
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-04-06
- Volume
- 22
- Issue
- 7
- Pages
- 3789
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8038770
- OpenAlex
- W3145310045
- Cited by
- 680
- References
- 99
- Citations by year
- 2026: 152 · 2025: 172 · 2024: 165 · 2023: 112 · 2022: 74 · 2021: 5
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Keywords
- polycystic ovary syndrome, low-grade inflammation, inflammatory cytokines, C-reactive protein, advanced glycation end products, RAGE, hyperinsulinemia, obesity, endothelial dysfunction, oxidative stress, cardiovascular risk, pregnancy complications, hyperandrogenism, insulin resistance
- MeSH terms
- Aging, C-Reactive Protein, Chronic Disease, Diabetes Mellitus, Type 2, Female, Humans, Inflammation, Obesity, Polycystic Ovary Syndrome, Cytokines, Metabolic Syndrome, Endothelial Cells, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.